Lv1
30 积分 2023-02-23 加入
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
3天前
已完结
Eleven clinical trials that will shape medicine in 2026
2个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
3个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
5个月前
已完结
Soft Drink Consumption and Depression Mediated by Gut Microbiome Alterations
6个月前
已关闭
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
7个月前
已完结
Association between metabolic profiles in urine and bone mineral density of pre- and postmenopausal Chinese women
7个月前
已完结
Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians
8个月前
已完结
皖公网安备34019202002308
